Skip to main content

News

Latest News

January 26, 2023

Washington, D.C. (Jan. 26, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement after Democratic Leader Hakeem Jeffries announced the members of the Committee for the 118th Congress:

Issues: Administration

January 24, 2023

Washington, D.C. (Jan. 24, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement after classified documents were found in former Vice President Mike Pence's private residence:


January 12, 2023

Washington, D.C. (Jan. 12, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement after Attorney General Merrick Garland announced a special counsel to review documents turned over by President Biden:

Issues: Administration

January 11, 2023

Washington, D.C. (Jan. 11, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement on House Republicans passing H.R. 26, which politicizes reproductive health care and criminalizes doctors and nurses who provide abortion services, and H. Con. Res. 3, which ignores the spike in violence and threats to abortion providers and patients:

Issues: Health Care

January 11, 2023

Washington, D.C. (Jan. 11, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement after Oversight Committee Chair James Comer announced plans to hold a hearing with former Twitter executives next month:


December 29, 2022

Washington D.C. (Dec. 29, 2022)—Today, Oversight and Reform Committee Chairwoman Carolyn B. Maloney (D-NY) and Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ) released a staff report following an 18-month investigation into the Food and Drug Administration's (FDA) regulatory review and approval process of Biogen's Alzheimer's disease drug Aduhelm, and Biogen's pricing of Aduhelm.


December 23, 2022

Washington, D.C. (Dec. 23, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, released the following statement regarding the Committee's activity for the 117th Congress:


December 22, 2022

Washington, D.C. (Dec. 22, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, Rep. Jamie Raskin, Chairman of the Subcommittee on Civil Rights and Civil Liberties, and Rep.


December 22, 2022

Washington, D.C. (Dec. 22, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, released the following statement after Rep. Jamie Raskin (D-MD) was elected Ranking Member of the Committee on Oversight and Reform for the 118th Congress:


December 20, 2022

Washington D.C. (Dec. 20, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, released the following statement after the United States Postal Service announced a historic investment to electrify 75 percent of its fleet over the next five years and committed to purchasing only electric Next Generation Delivery Vehicles (NGDV) starting in 2026:

Issues: Postal Service